Search by Drug Name or NDC
NDC 49281-0590-05 MenQuadfi 10; 10; 10; 10 ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL Details
MenQuadfi 10; 10; 10; 10 ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL
MenQuadfi is a INTRAMUSCULAR INJECTION, SOLUTION in the VACCINE category. It is labeled and distributed by Sanofi Pasteur Inc.. The primary component is NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN; NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN; NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CON.
Product Information
| NDC | 49281-0590 |
|---|---|
| Product ID | 49281-590_2c61477d-7c6b-498c-b465-49d666ac2fb9 |
| Associated GPIs | 17200040462000 |
| GCN Sequence Number | 080981 |
| GCN Sequence Number Description | mening vac A,C,Y,W135,c-tet/PF VIAL 10 MCG/0.5 INTRAMUSC |
| HIC3 | W7Q |
| HIC3 Description | GRAM NEGATIVE COCCI VACCINES |
| GCN | 47972 |
| HICL Sequence Number | 039607 |
| HICL Sequence Number Description | MENINGOCOCCAL VACCINE A,C,Y AND W-135,CONJ TETANUS TOXOID/PF |
| Brand/Generic | Brand |
| Proprietary Name | MenQuadfi |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGA |
| Product Type | VACCINE |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAMUSCULAR |
| Active Ingredient Strength | 10; 10; 10; 10 |
| Active Ingredient Units | ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL |
| Substance Name | NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN; NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN; NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CON |
| Labeler Name | Sanofi Pasteur Inc. |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA125701 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 49281-0590-05 (49281059005)
| NDC Package Code | 49281-590-05 |
|---|---|
| Billing NDC | 49281059005 |
| Package | 5 VIAL, SINGLE-DOSE in 1 CARTON (49281-590-05) / .5 mL in 1 VIAL, SINGLE-DOSE (49281-590-58) |
| Marketing Start Date | 2023-06-30 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |